pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Paxlovid
drug
save

nirmatrelvir + ritonavir

pre_registrationupdated 6mo ago
by $PFE PFIZER INC
community read0 votes

🐶 often sniffed alongside

top 3
  • tagApproval14 co-mentions · 7 sources
  • drugPAXLOVID (COPACKAGED)14 co-mentions · 7 sources
  • tagSmall Molecule7 co-mentions · 7 sources

all catalysts(0)

nothing on the calendar yet

Trials studying nirmatrelvir + ritonavir

  • phase2Early-stage Trial to Determine a Safe and Effective Dose for Ratutrelvir in Patients With Mild to Moderate COVID-19recruitingn=90
  • phase1A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlovid in Healthy Participantswithdrawn

News(10)

  • Moderna enjoys stable vaccine sales thanks to global COVID uptake
    While Moderna preps an entry to the oncology market next year with a personalized cancer vaccine, COVID sales are holding steady with several other vaccine launches underway around the world.
    biospace · 12d ago
  • Pfizer, fresh to China’s obesity market, looks to Viagra model to compete
    Pfizer is calling upon lessons learned from one of the first drugs ever made available on the internet—Viagra—as it commercializes a new obesity drug in China.
    biospace · 15d ago
  • Pfizer flat in Q3 despite 32% growth for new and acquired products
    Sales of assets from Seagen and Biohaven grew in the third quarter, but it wasn’t enough for Pfizer to overcome declines across the Prevnar and COVID franchises.
    biospace · 16d ago
  • Telemedicine company offers GLP-1s for addiction
    A CDC Covid restructuring, public trust in Fauci, and more health news from Morning Rounds
    stat · 2mo ago
  • An administrative gap delays access to new pancreatic cancer treatment
    A new wave of illegal fruity vapes, more and more kids on GLP-1s, and other health news from Morning Rounds
    stat · 2mo ago
  • Disabled workers at greater risk of losing health insurance
    An organ transplant first, new details on ADA conference controversy, and more health news from Morning Rounds
    stat · 2mo ago
  • HHS flip-flops on disability lawsuit
    Drug overdose deaths decreasing, a path to patients for AI devices, and more health news from Morning Rounds
    stat · 2mo ago
  • HHS spins a tale of a would-be content creator child
    The next DSM and the algorithm, an unexpected discovery on alpha-gal syndrome, and more health news from Morning Rounds
    stat · 2mo ago
  • Paxlovid did not help long Covid, study finds
    New Trump drug pricing deals, weed edibles and driving research, and more health news from Morning Rounds
    stat · 2mo ago
  • Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch
    Some analysts see warning signs in crucial drug launches from Gilead and Merck, while an important trial readout could change Pfizer’s growth trajectory.
    biopharma_dive · 3mo ago
view all news mentions →
brand
Paxlovid
generic
nirmatrelvir + ritonavir
indication
Coronavirus Disease 2019 (COVID-19)
phase
pre_registration
Data sources
ClinicalTrials.gov
last refreshed 3h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?